LXRX
Lexicon Pharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
LXRX fundamentals
Lexicon Pharmaceuticals (LXRX) released its earnings on Nov 6, 2025: revenue was 14.10M (YoY +705.71%), beat estimates; EPS was -0.04 (YoY +77.78%), beat estimates.
Revenue / YoY
14.10M
+705.71%
EPS / YoY
-0.04
+77.78%
Report date
Nov 6, 2025
LXRX Earnings Call Summary for Q3,2025
- Pipeline Momentum: Pilobafidin phase 2 data support phase 3 readiness; LX9851 IND filing imminent; Sonata HCM trial on track.
- Financial Strength: Q3 2025 revenue up 700% YoY; operating expenses reduced by 78% since 2024.
- Strategic Focus: Transitioning to R&D-driven model with disciplined capital allocation; exploring innovative commercial strategies.
- Regulatory Catalysts: FDA feedback on Zingquista expected Q4; sotagliflozin presentations at AHA and HCM Society highlight broad cardiometabolic potential.
EPS
Revenue
Revenue & Expenses
LXRX has released its 2025 Q3 earnings report, with revenue of 14.18M, reflecting a YoY change of 710.40%, and net profit of -12.77M, showing a YoY change of 80.30%. The Sankey diagram below clearly presents LXRX's revenue sources and cost distribution.
Key Indicators
Lexicon Pharmaceuticals (LXRX) key financial stats and ratios, covering profitability, financial health, and leverage.
Lexicon Pharmaceuticals (LXRX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Lexicon Pharmaceuticals (LXRX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Lexicon Pharmaceuticals (LXRX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Lexicon Pharmaceuticals (LXRX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Lexicon Pharmaceuticals (LXRX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Lexicon Pharmaceuticals's management provide for the next earnings period?What is Lexicon Pharmaceuticals's latest dividend and current dividend yield?What were the key takeaways from Lexicon Pharmaceuticals’s earnings call?Did Lexicon Pharmaceuticals beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Lexicon Pharmaceuticals year over year?What factors drove the changes in Lexicon Pharmaceuticals's revenue and profit?What is Lexicon Pharmaceuticals's gross profit margin?What does Lexicon Pharmaceuticals do and what are its main business segments?
